INTUITUS
12.10.2016 09:09:49 CEST | Business Wire | Press release
The MD of one of Europe’s leading private equity advisers has warned that technology and IT ‘red flags’ could put at risk the exits or re-financings of companies that would otherwise be seeing deals get over the line successfully with international and London-based institutions and corporate investors.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161012005052/en/
While various reports have indicated a surge of interest from foreign investors in UK private-equity-owned assets during the second half of 2016 - partly driven by a sharp drop in the value of the pound - that shows signs of continuing into 2017, forward planning in the twelve months leading up to the exit can have a huge impact not only on deal value but whether the deal concludes.
Fixing technology and IT operations can require considerable time and effort, warns Intuitus MD and founder, Calum Stewart:
“Technology has never been more critical to exit readiness than it is today and our client base consistently tells us that if IT problems are discovered in the lead-up to exit it is often too late to redress the situation before potential buyers start taking a look. Potential issues and deal-breakers include intellectual property disputes, contractual disputes, capacity planning and product development problems.”
“In a typical sale process, any significant technology or IT problem presenting a current or future risk will be likely to delay the process and may also depreciate the value that you’re trying to extract. In the worst instance, it could even derail the sale completely.”
- Intuitus - whose private equity clients include Inflexion, The Carlyle Group, Dunedin, Triton and Scottish Equity Partners - is in on track to advise on over 100 deals during 2016, with approximately 30% of deal activity involving non-UK assets.
- Intuitus offers its private equity and corporate clients commercially-focused, independent technology and IT expertise throughout the full investment life cycle - at the point of acquisition, during ownership and at exit. Supported by a network of internationally-experienced consultants, mainly former CEOs, CTOs, CIOs and IT Directors from a wide range of industry sectors, and managed through the company’s unique, integrated delivery model, the company is targeting expansion in the UK, Benelux, France, Germany and the Nordics in 2017.
- Intuitus won the Specialist Adviser of the Year award at The Private Equity Awards 2016.
Follow Intuitus on LinkedIn and Twitter
View source version on businesswire.com: http://www.businesswire.com/news/home/20161012005052/en/
Contact:
Intuitus
Calum Stewart
+44 (0)131 618 0512
or
Freer
Consultancy
Nick Freer
+44 (0)7841 571 871
nick@freerconsultancy.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Announces Novel Quantum Error Correction Approach Toward Fault-Tolerant Quantum Computing9.6.2026 09:00:00 CEST | Press release
New approach delivers cutting edge performance, while significantly reducing hardware complexity IQM Quantum Computers, the global leader in superconducting quantum computers, has developed a novel quantum error-correcting code that achieves up to three orders of magnitude lower logical error rates than the surface code, also requiring up to eight times fewer physical qubits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609533201/en/ IQM´s breakthrough technology, called barbell codes. Unlike many alternative high-performance quantum error-correction approaches, the new code also maintains a comparatively low hardware complexity, marking a significant advancement toward scalable fault-tolerant quantum computing. Quantum error correction remains one of the defining challenges in the race toward practical quantum computing. Errors introduced by noise must be corrected faster than they accumulate, a requirement that previo
Estonia Raises the Bar for Secure Digital Identity in Europe With New eID Cards Developed With Thales9.6.2026 09:00:00 CEST | Press release
The Estonian Police and Border Guard Board has begun the issuance of the country’s new electronic identity (eID) cards, marking a major milestone in the ongoing modernisation of Estonia’s renowned digital identity programme. This new generation of cards has been developed in partnership with Thales under an eight-year contract covering the full lifecycle of national identity documents - from issuance to personalisation -for residents, citizens, and specific groups such as diplomats or refugees. The advanced eID cards1 feature cutting-edge embedded security elements that can be upgraded to counter emerging cyber threats, ensuring citizens’ digital transactions remain protected over time. With increasing cyber risks and the rapid evolution of digital public services, Estonia is reinforcing the security, durability and adaptability of the documents that underpin its digital society: identity cards, residence permit cards, e-resident digital identity cards, diplomatic identity cards, certi
Longpoint Expands into Germany and the Netherlands, Targeting €400 Million of Infill Logistics Investment9.6.2026 09:00:00 CEST | Press release
Firm appoints Gijs Vissers and Benedict Stichel as country heads to lead growth across two key European logistics markets Longpoint Partners today announced its expansion into Germany and the Netherlands, extending its infill industrial strategy into two of Europe’s most supply-constrained logistics markets. The firm is establishing a presence in high-demand locations, including Düsseldorf, Frankfurt, and the Randstad, and plans to deploy approximately €400 million into logistics assets near major population centers and transportation corridors. “We are excited to expand Longpoint’s infill industrial strategy into Germany and the Netherlands,” said Dwight Angelini, Founding and Managing Partner of Longpoint Partners. “These are highly attractive logistics markets with strong fundamentals, limited supply, and a clear need for high-quality light industrial and logistics space. With Gijs and Benedict leading our local efforts, we have the market knowledge, relationships, and discipline to
ISO/TC 251 Recognizes Ampowr as the Only BESS Operator With a Fully Integrated ISO Stack9.6.2026 09:00:00 CEST | Press release
ISO/TC 251 and NEN, the Netherlands national standards body, profile Ampowr alongside Rijkswaterstaat, the US Army Corps of Engineers, Novo Nordisk and Veolia after an in-depth methodology interview with Executive Director Andrew Elwell. ISO/TC 251, the international technical committee that authors the ISO 55000 family of asset management standards, has published a case study profiling Ampowr's integrated certification methodology. Authored by NEN, the Dutch national standards body, the study is now publicly available in the ISO/TC 251 case studies library alongside profiles of Rijkswaterstaat, the US Army Corps of Engineers, Novo Nordisk, and Veolia. ISO/TC 251 approached Ampowr directly. NEN subsequently conducted an in-depth interview with Executive Director Andrew Elwell, examining how Ampowr operates its five certifications (ISO 9001, ISO 14001, ISO 45001, ISO 27001 and ISO 55001), as a single integrated system rather than separate compliance silos. "To our knowledge we are the o
Bial Reports Topline Results From ACTIVATE Phase 2b Study in GBA‑Associated Parkinson’s9.6.2026 08:00:00 CEST | Press release
Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced today that the Phase 2b ACTIVATE study of BIA 28-6156 (pariceract) in patients with Parkinson’s who have a pathogenic variant in the GBA1 gene (GBA-PD) did not meet its primary, nor the key secondary efficacy endpoints, meaning that BIA 28-6156 failed to slow the progression of GBA-PD versus placebo. BIA 28-6156 proved to be generally well tolerated in the study, with no unexpected safety concerns arising. While the study data provide valuable scientific information and contribute to a broader understanding of Parkinson’s biology, BIA 28-6156 did not demonstrate significant differentiation from placebo on the primary or key secondary endpoints measured. Based on the lack of demonstrated efficacy in this study, Bial has made the decision to discontinue further development of BIA 28-6156 for this indication. “We are disappointed with the outcome of the Phase 2b ACTIVATE study, as th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom